Well, this one's an ambulance-chaser class action. And there's certainly no evidence yet to give it any merit.
There definitely won't be a class-action from the patients who were taking the drug, as it was really helping a lot of them, all of whom were suffering from a terminal disease.
If there's any class action from the patients, they'd sue to get it back on the market.
Edit: Though I value the company substantially north of its current price, I think the run of the past two days has gotten way ahead of itself. It needs to pull back and try again, more slowly this time.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.